RT Journal Article
SR Electronic
T1 1131 Anti-CLEC2D-TLR9 agonist conjugate binds to and internalizes CLEC2D on myeloid cells, plasmacytoid DCs and B cells leading to robust TLR pathway activation and inflammatory cytokine production
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1243
OP A1243
DO 10.1136/jitc-2023-SITC2023.1131
VO 11
IS Suppl 1
A1 Tabrizi, Siamak
A1 Nandivada, Vandana
A1 Irvine, Frano
A1 Goshert, Caitlin
A1 Nichols, Kelly
A1 Scanlon, Elizabeth
A1 Huggins, Matthew
A1 Flick, Heather
A1 Tang, Ming
A1 Tan, Seng-Lai
A1 Wang, Xianzhe
A1 Malu, Shruti
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1243.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.